FLUSPIRILENE, AN INJECTABLE, AND PENFLURIDOL, AN ORAL LONG‐ACTING, NEUROLEPTIG
- 23 August 1972
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 48 (4) , 315-331
- https://doi.org/10.1111/j.1600-0447.1972.tb04372.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Controlled trial of Penfluridol in Acute PsychosisBMJ, 1971
- A QUANTITATIVE STUDY OF NEUROLEPTIC‐INDUCED EXTRAPYRAMIDAL SYMPTOMS AND THEIR RESPONSE TO DEXETIMIDE, A POTENT AND LONG‐ACTING ANTIPARKINSONIAN AGENTActa Psychiatrica Scandinavica, 1971
- CLINICAL EVALUATION OF THE LONG‐ACTING INJECTABLE NEUROLEPTIC, FLUSPIRILENE, IN THE TREATMENT OF SCHIZOPHRENIC AND MENTALLY RETARDED PATIENTSActa Psychiatrica Scandinavica, 1971
- Maintenance Therapy of Chronic Psychotic Patients with a Weekly Oral Dose of R16 341. A Controlled Double‐Blind StudyThe Journal of Clinical Pharmacology and The Journal of New Drugs, 1970
- The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drugEuropean Journal of Pharmacology, 1970
- A Rating Scale of the Mental State: For Use in the Chronic Population of the Psychiatric HospitalThe British Journal of Psychiatry, 1967